Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early-life stress, the endocannabinoid system, and fear memory extinction
2017-004823-66Phase 2Terminated
- Sponsor
- Radboudumc
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sodium oxybate and hydrocortisone in post-traumatic stress disorder (PTSD), anxiety disorder and mental disorder (2 arms), sponsored by Radboudumc. Primary endpoint: Primary safety learning endpoint. Started Mar 2019; status: terminated.
02
Drugs
sodium oxybatehydrocortisone
03
Conditions
post-traumatic stress disorder (PTSD)anxiety disordermental disorder
Beyond the preview
Go deeper on 2017-004823-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004823-66.